# Willingness of Saudi cancer patients to take part in clinical trials

Source: https://onco.cc/key-papers/paper-alkaiyat-trial-willingness-saudi-jco-go-2026/  
OnCo record `paper-alkaiyat-trial-willingness-saudi-jco-go-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Among 367 cancer patients surveyed in Saudi Arabia in 2023 to 2024, 31.6% were willing to join a clinical trial against 64% for an observational study; fear of side effects and lack of information were the main barriers.

## Summary

Published as "Exploring Factors Affecting Participation in Oncology Clinical Trials in Saudi Arabia: Insights Into Willingness and Barriers". A cross-sectional study with systematic sampling, December 2023 to June 2024, using patient questionnaires and medical charts.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: JCO Global Oncology
- Year: 2026
- DOI: 10.1200/go-25-00254
- Authors: Alkaiyat M, Alshammari K, Cois A.
- Findings: 367 patients took part; 59.8% had stage IV disease and only 1.9% had been in a trial before.; Willingness was 64% for observational studies and 31.6% for clinical trials.; Barriers were fear of side effects (61.6%), lack of information (46.3%) and concerns about the product (41.6%); having a friend or relative who had joined a trial raised willingness (odds ratio 3.48).
- What it means: Few Saudi cancer patients have been in a trial and most are reluctant; better information and the treating doctor's involvement may help.
- Caveats: The abstract does not name the hospital or hospitals; results may not generalise across the country.

## Sources

- JCO Glob Oncol 2026: https://doi.org/10.1200/go-25-00254
- PubMed: https://pubmed.ncbi.nlm.nih.gov/42485596/

## Connected records

- institutions: [National Cancer Center, Saudi Health Council](https://onco.cc/institutions/saudi-national-cancer-center/)

---
JSON: https://onco.cc/api/v1/entities/paper-alkaiyat-trial-willingness-saudi-jco-go-2026.json